{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:16:41Z","timestamp":1791303401533,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005147","name":"Random House","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011150","name":"Global Environment Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.biopha.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T21:34:50Z","timestamp":1502487290000},"page":"1010-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk"],"prefix":"10.1016","volume":"94","author":[{"given":"Mohammad","family":"Adil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nizam","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Dattatraya","family":"Kandhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.08.001_bib0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/TCRM.S131945","article-title":"Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis","volume":"13","author":"Moayeri","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.biopha.2017.08.001_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.3002","article-title":"Type 2 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort (FRAILCO)","volume":"32","author":"Wallander","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0015","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.biopha.2017.08.001_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.biopha.2017.08.001_bib0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2017.08.001_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.biopha.2017.08.001_bib0035","series-title":"The Effect of Thiazolidinediones on Bone Mineral Density and Bone Turnover: Systematic Review and Meta-analysis","author":"Billington","year":"2015"},{"key":"10.1016\/j.biopha.2017.08.001_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","article-title":"Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials","volume":"68","author":"Zhu","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2017.08.001_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharep.2017.05.008","article-title":"Effect of anti-diabetic drugs on bone metabolism: evidence from preclinical and clinical studies","author":"Adil","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2017.08.001_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cmet.2010.04.015","article-title":"PGC1\u03b2 mediates PPAR\u03b3 activation of osteoclastogenesis and rosiglitazone-induced bone loss","volume":"11","author":"Wei","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2017.08.001_bib0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00774-014-0632-4","article-title":"Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats","volume":"33","author":"Smith","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.biopha.2017.08.001_bib0060","doi-asserted-by":"crossref","first-page":"e0168569","DOI":"10.1371\/journal.pone.0168569","article-title":"Protective effects of vildagliptin against pioglitazone-induced bone loss in type 2 diabetic rats","volume":"11","author":"Eom","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5475","article-title":"A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0070","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/02770903.2016.1180530","article-title":"Berberine improves airway inflammation and inhibits NF-kappaB signaling pathway in an ovalbumin-induced rat model of asthma","volume":"53","author":"Li","year":"2016","journal-title":"J. Asthma"},{"key":"10.1016\/j.biopha.2017.08.001_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-13-0184","article-title":"Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats","volume":"218","author":"Shan","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.apsb.2012.06.003","article-title":"Effects and mechanisms of berberine in diabetes treatment","volume":"2","author":"Yin","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2017.08.001_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2013.37.1.1","article-title":"AMPK and exercise: glucose uptake and insulin sensitivity","volume":"37","author":"O'Neill","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.biopha.2017.08.001_bib0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2017.08.001_bib0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bone.2010.12.003","article-title":"Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2","volume":"48","author":"Jang","year":"2011","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.biopha.2017.08.001_bib0100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joen.2012.03.010","article-title":"Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand\/osteoprotegerin","volume":"38","author":"Liu","year":"2012","journal-title":"J. Endod."},{"key":"10.1016\/j.biopha.2017.08.001_bib0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2007.11.013","article-title":"Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways","volume":"580","author":"Hu","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.080325","article-title":"Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK","volume":"23","author":"Lee","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1055\/s-0030-1250040","article-title":"Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats","volume":"76","author":"Xu","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2017.08.001_bib0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.biocel.2005.09.007","article-title":"Animal models of type 2 diabetes with reduced pancreatic \u03b2-cell mass","volume":"38","author":"Masiello","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0125","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0130","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","article-title":"DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats","volume":"307","author":"Glorie","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2017.08.001_bib0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12011-010-8703-4","article-title":"Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats","volume":"140","author":"Erdal","year":"2011","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0140","first-page":"2","article-title":"Spirulina reverses histomorphological changes in diabetic osteoporosis in pioglitazone treated rats","author":"Devesh","year":"2012","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.biopha.2017.08.001_bib0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11011-013-9411-5","article-title":"Berberine chloride improved synaptic plasticity in STZ induced diabetic rats","volume":"28","author":"Moghaddam","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2017.08.001_bib0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/aps.2013.11","article-title":"Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain beta-amyloid through PPARgamma activation","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2017.08.001_bib0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/aps.2015.136","article-title":"Berberine protects rat heart from ischemia\/reperfusion injury via activating JAK2\/STAT3 signaling and attenuating endoplasmic reticulum stress","volume":"37","author":"Zhao","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2017.08.001_bib0160","first-page":"19","article-title":"Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus","volume":"131","author":"Pari","year":"2002","journal-title":"Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1139\/o76-051","article-title":"Acid phosphatases: androgen dependent markers of rat prostate","volume":"54","author":"Tenniswood","year":"1976","journal-title":"Can. J. Biochem."},{"key":"10.1016\/j.biopha.2017.08.001_bib0170","doi-asserted-by":"crossref","first-page":"97613","DOI":"10.1039\/C6RA17141A","article-title":"Quercetin-loaded solid lipid nanoparticles improve osteoprotective activity in an ovariectomized rat model: a preventive strategy for post-menopausal osteoporosis","volume":"6","author":"Ahmad","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2017.08.001_bib0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2016.05.015","article-title":"Sodium arsenite-induced myocardial bruise in rats: ameliorative effect of naringin via TGF-beta\/Smad and Nrf\/HO pathways","volume":"253","author":"Adil","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2017.08.001_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbi.2014.05.012","article-title":"Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats","volume":"219","author":"Kandhare","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2017.08.001_bib0185","first-page":"2129","article-title":"Diabetogenic action of streptozotocin: relationship of dose to metabolic response","volume":"48","author":"Junod","year":"1969","journal-title":"J. Diabetes Investig."},{"issue":"13","key":"10.1016\/j.biopha.2017.08.001_bib0190","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/jf101194f","article-title":"Anti-diabetic effects of Monascus purpureus NTU 568 fermented products on streptozotocin-induced diabetic rats","volume":"58","author":"Shi","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.08.001_bib0195","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00125-007-0698-9","article-title":"Effects of peroxisome proliferator-activated receptor (PPAR)-\u03b1 and PPAR-\u03b3 agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus","volume":"50","author":"Bajaj","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2017.08.001_bib0200","doi-asserted-by":"crossref","first-page":"e0166378","DOI":"10.1371\/journal.pone.0166378","article-title":"Identification and verification of potential therapeutic target genes in berberine-treated zucker diabetic fatty rats through bioinformatics analysis","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.001_bib0205","doi-asserted-by":"crossref","first-page":"e0117516","DOI":"10.1371\/journal.pone.0117516","article-title":"Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status","volume":"10","author":"Ibrahim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.001_bib0210","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2017.08.001_bib0215","doi-asserted-by":"crossref","first-page":"e16556","DOI":"10.1371\/journal.pone.0016556","article-title":"Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.001_bib0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0026-0495(85)90101-5","article-title":"Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes","volume":"34","author":"Ishida","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2017.08.001_bib0225","first-page":"132","article-title":"The relationship of diabetes mellitus and body weight to osteoporosis in elderly females","volume":"96","author":"Meema","year":"1967","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.biopha.2017.08.001_bib0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/nu8030133","article-title":"Effects of trigonelline, an alkaloid present in coffee, on diabetes-induced disorders in the rat skeletal system","volume":"8","author":"Folwarczna","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2017.08.001_bib0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.08.001_bib0245","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2017.03.004","article-title":"Zinc supplementation reduces RANKL\/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats","volume":"40","author":"Ferreira","year":"2017","journal-title":"Nutr. Res."},{"key":"10.1016\/j.biopha.2017.08.001_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6823-9-10","article-title":"Different skeletal effects of the peroxisome proliferator activated receptor (PPAR) \u03b1 agonist fenofibrate and the PPAR\u03b3 agonist pioglitazone","volume":"9","author":"Syversen","year":"2009","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.biopha.2017.08.001_bib0260","first-page":"2012","article-title":"Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption","author":"Xue","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.biopha.2017.08.001_bib0265","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1038\/ncomms11149","article-title":"Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development","volume":"7","author":"Liu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2017.08.001_bib0270","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ajpath.2016.01.016","article-title":"Runx2 controls bone resorption through the down-regulation of the wnt pathway in osteoblasts","volume":"186","author":"Haxaire","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0275","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11914-015-0267-y","article-title":"An overview of the metabolic functions of osteocalcin","volume":"13","author":"Wei","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2017.08.001_bib0280","article-title":"Zoledronic acid improves bone quality in the streptozotocin-induced diabetes rat through affecting the expression of the osteoblast-regulating transcription factors","author":"Cui","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.biopha.2017.08.001_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10059-012-2240-z","article-title":"The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption","volume":"33","author":"Cho","year":"2012","journal-title":"Mol. Cells"},{"key":"10.1016\/j.biopha.2017.08.001_bib0290","first-page":"201","article-title":"Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats","volume":"63","author":"Tsirella","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0295","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/meta.2002.34715","article-title":"Effects of berberine on glucose metabolism in vitro","volume":"51","author":"Yin","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2017.08.001_bib0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","article-title":"Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes","volume":"794","author":"Jin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.001_bib0305","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2008.08.034","article-title":"Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression","volume":"375","author":"Kanazawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.08.001_bib0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bone.2010.04.596","article-title":"AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass","volume":"47","author":"Shah","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2017.08.001_bib0315","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2017.08.001_bib0320","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.090732","article-title":"Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies","volume":"25","author":"Molinuevo","year":"2010","journal-title":"J. Bone Miner. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221732838X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221732838X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:31:15Z","timestamp":1776382275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221732838X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":64,"alternative-id":["S075333221732838X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.001","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}